Abbott Labs (ABT) operating cash flow was $9.6B in FY2025 (+12% YoY). The tables below show the complete quarterly and annual operating cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Cash Flow
Fiscal Year
Operating Cash Flow
YoY
2025
$9.6B
+12%
2024
$8.6B
+18%
2023
$7.3B
-24%
2022
$9.6B
-9%
2021
$10.5B
+33%
2020
$7.9B
+29%
2019
$6.1B
-3%
2018
$6.3B
+13%
2017
$5.6B
+74%
2016
$3.2B
+8%
2015
$3.0B
-19%
2014
$3.7B
+11%
2013
$3.3B
-64%
2012
$9.3B
+4%
2011
$9.0B
Recent Quarterly Operating Cash Flow
Quarter
Operating Cash Flow
Q1 2026
$1.3B
Q4 2025
$3.3B
Q3 2025
$2.8B
Q2 2025
$2.0B
Q1 2025
$1.4B
Q4 2024
$2.9B
Q3 2024
$2.7B
Q2 2024
$2.0B
Q1 2024
$1.0B
Q4 2023
$3.0B
Q3 2023
$1.9B
Q2 2023
$1.2B
Source: ABT on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.